chrisvoncsefalvay/vaers-outcomes huggingface dataset:
issue with her platelet/platelet count had gone up to more than 1 million; This spontaneous case was reported by a consumer and describes the occurrence of PLATELET COUNT INCREASED (issue with her platelet/platelet count had gone up to more than 1 million) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PLATELET COUNT INCREASED (issue with her platelet/platelet count had gone up to more than 1 million). At the time of the report, PLATELET COUNT INCREASED (issue with her platelet/platelet count had gone up to more than 1 million) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Platelet count: 1 million (High) gone up to more than 1 million.         No concomitant medications reported.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 06-Sep-2021: The follow-up information received contain significant information- event outcome updated to not recovered/ not resolved.
Lost hearing in right ear; pain; Sick; shingles; Suspected vaccination failure; This case was reported by a consumer and described the occurrence of vaccination failure in a 80-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 31st March 2018, the patient received the 2nd dose of Shingrix. On 25th January 2018, the patient received the 1st dose of Shingrix. On 8th December 2021, 1348 days after receiving Shingrix and 1413 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles (serious criteria other: serious as per reporter). On an unknown date, the patient experienced deafness unilateral (serious criteria GSK medically significant), pain and sickness. The patient was treated with valaciclovir (Valacyclovir). On an unknown date, the outcome of the vaccination failure, deafness unilateral, shingles, pain and sickness were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, deafness unilateral, shingles, pain and sickness to be related to Shingrix and Shingrix.  Additional details were provided as follows: The patient self-reported this case. The patient stated he/she was reporting a serious bout of shingles, even though he/she was vaccinated with Shingrix (2 doses). The patient had been in a lot of pain with shingles and had lost the hearing in his/her right ear. The patient stated he/she was very sick and in a lot of pain, which he/she did not expect because he/she was fully vaccinated with Shingrix. On 8th December 2021, the patient was diagnosed with shingles. The patient provided contact details of doctor. The patient further asked if there should be a Shingrix booster. This case was considered as suspected vaccination failure as details regarding laboratory test confirming shingles were unknown at the time of reporting.
After 13 hours after receiving Diphtheria, Tentanus, Petussis, Polio, Haemophilus, Influenza B, and Pneumococcal, she had a focal seizure.  After arriving at the emergency room at medical center, she had a grand mall seizure which required her to be flown to another Hospital. She continued to have seizures after leaving the hospital with being on anti-seizure medication.  We took her to another clinic for a second opinion. The doctor put her on different anti-seizure medication which continued to not work.  They then advised us to go on the ketogenic diet which we were sent to another Hospital.  After going on the diet and trying once again other anti-seizure medication, nothing continues to work.  She has had 15 EEG's, 1 MRI, 3 EKGS, 1 Spinal Tap, 1 Muscle Biopsy.  The following are the drugs she has been on Calproic Acid, Depakote, Dilantin, Clonazepan, Phenobarbitol, Tegretol, Topamax, Primidone.  She is currently on Felbemate and also receiving ACTH shot once a day.  They are now talking about putting in a vagal nerve stimulator. The medical record received on 8/22/03 states UTI. The medical record states an allergic reaction.
scared; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FEAR (non-serious), outcome "unknown", described as "scared".  Additional information: Caller is asking for the chemical composition of the Pfizer COVID-19 vaccine, saying the vaccine that is killing everybody, caller and her grandmother recently received the vaccine. They are scared with the vaccine than they are with COVID. They called recently and were yelled at like mental patients. They don't understand why they need to get the vaccine to get a job. Asking are they the only one who gets all these complications.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
flu like symptoms; Body aches; headache; feeling unwell; This is a spontaneous report from a contactable consumer (patient). A 45-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: EM9810, Expiration Date: Jun2021) via unspecified route on 11Feb2021 at 11:30 AM in the left arm as single dose for covid-19 immunisation at hospital. Patient's medical history included GERD, take 20 mg Nexium and allergic for clyndamycin antibiotics. Concomitant medications not included. The patient did not receive any other vaccines in 4 weeks. The patient was not diagnosed with COVID-19 prior or since the vaccination. On 12Feb2021, at 02:00 AM the patient experienced body aches, flu like symptoms, feeling unwell and headache for about 2 days. After a day 2 days of headache still lingers. Events were treated with Tylenol twice a day and once on next day. Outcome of events was recovered with lasting effects.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021363289 Same reporter/ drug, different patients/ events;US-PFIZER INC-2021363288 Same reporter/ drug, different patients/ events.
pt recvd vax approx 2pm;2:10pm was standing leaning against counter;RN observing pt & began talking to him; client fainted;placed on floor;BP 110/72 P68; cold & clammy;cold cloth applied;2:12pm able to talk;2:15 BP 110/80;gave 6 oz coke;
Pt reported localized swelling, redness, warmth at injection site approx. 3 in x 3 in, no fever, no itching, no other symptoms.
Approx 8-10 pts have exp diarrhea & stomach cramping w/in 48 hrs post vax; tx included Imodium; sx resolved w/in 24 hrs following treatment;
Aprox 20 hours later i became sick, body aches, so tired i couldn't function normally. 101 fever that lasted 48 hours.  Elevated resting heart rate even now months later.
Pt reports increased (new) joint pains in both elbows, both wrists and both MP joints (thumbs).
Dizzy, headache, feeling weird/off, stomach off.  Happened once the first week, felt crappy the second week, more sporadic the 3rd week, but happened again today for the first time in 4 days, for a few hours. Starting my 4th week.
She had reaction to any kind of medicine or vaccine; restless; felt sleepy; gland swollen; shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (She had reaction to any kind of medicine or vaccine), RESTLESSNESS (restless), SOMNOLENCE (felt sleepy), VACCINATION SITE LYMPHADENOPATHY (gland swollen) and ARTHRALGIA (shoulder pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, the patient experienced RESTLESSNESS (restless), SOMNOLENCE (felt sleepy), VACCINATION SITE LYMPHADENOPATHY (gland swollen) and ARTHRALGIA (shoulder pain). On an unknown date, the patient experienced VACCINATION COMPLICATION (She had reaction to any kind of medicine or vaccine). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION (She had reaction to any kind of medicine or vaccine), RESTLESSNESS (restless), SOMNOLENCE (felt sleepy), VACCINATION SITE LYMPHADENOPATHY (gland swollen) and ARTHRALGIA (shoulder pain) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.
Pain, weakness and limited mobility on right arm/shoulder since 2 days after receiving the hepatitis B vaccine. 6 sessions of physical therapies.
Bells Palsy, left half of face 4/13/21  Preceded by tingling tongue and metallic taste/affected taste 4/10/2021
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 07-SEP-2012, a healthcare provider at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 21-APR-2014, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
A report has been received from a Pharmacist concerning a 4 year old, subject of unknown gender, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. FLUMIST was inadvertently frozen overnight on January 18 for a maximum for 24 hours. The batch was not quarantined and instead, was later administered to a patient on 21-Jan-2013. Product was not expired. The outcome of the event of previously frozen FLUMIST administered is unknown. The report was considered to be non-serious.
received the last dose of ROTATEQ series on an unspecified date when the patient was 8 months and 29 days old and that the dose was administered outside of the Prescribing Information; No adverse effects reported; This spontaneous report was received from a medical assistant referring to an 8 months and 29 days old patient. Information about pertinent medical history, drug reaction/allergy and concomitant medication was not provided.  On an unknown date, the patient was vaccinated with the last dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) series (vaccine dosage detail, route of administration, lot# and expiration date were not reported) for prophylaxis. This dose was administered outside of the prescribing information (inappropriate schedule of vaccine administered). No adverse effects were reported.
SHAKES; WICKED BAD FEVER; This spontaneous report received from a patient via a company representative concerned a 32 year old male. The patient's weight was 170 pounds, and height was 175.26 centimeters. The patient's past medical history included: covid (sick with COVID before the first vaccination), and concurrent conditions included: non alcohol user, and non smoker. The patient was previously treated with influenza vaccine for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 180860P expiry: UNKNOWN) .5 ml, administered on 27-MAR-2021 for prophylactic vaccination. Age at time of vaccination 32 years old. Concomitant medications included ascorbic acid/betacarotene/biotin/boron/calcium/calcium pantothenate/chloride/chromium/colecalciferol/copper/cyanocobalamin/folic acid/iodine/iron/lycopene/magnesium/manganese/molybdenum/nickel/nicotinamide/phosphorus/potassium/pyridoxine hydrochloride/retinol/riboflavin/selenium/silicon dioxide/thiamine/tin/tocopheryl acetate/vanadium/vitamin k nos/zinc. On 2021, Laboratory data included: Laboratory test (NR: not provided) not reported. On 27-MAR-2021, the patient experienced wicked bad fever. Laboratory data included: Body temperature (NR: not provided) fever of 102. On an unspecified date, the patient experienced shakes. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.9 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the wicked bad fever and shakes was not reported. This report was non-serious. This case, involving the same patient is linked to 20220526805.
Itching diffuse rash started 1 day ago. It is constant in duration. It is worse. Its aggravated by scratching.
Said she had every side effect listed; Sickness; Fatigue; Muscle pain; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Said she had every side effect listed), ILLNESS (Sickness), FATIGUE (Fatigue), MYALGIA (Muscle pain) and HEADACHE (Headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B218) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Apr-2021, the patient experienced ADVERSE EVENT (Said she had every side effect listed), ILLNESS (Sickness), FATIGUE (Fatigue), MYALGIA (Muscle pain), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, ADVERSE EVENT (Said she had every side effect listed), ILLNESS (Sickness), FATIGUE (Fatigue), MYALGIA (Muscle pain), HEADACHE (Headache) and PYREXIA (Fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included High blood pressure pill , medicine for cholesterol and pill for irregular heart beat, all to be taken every day respectively. Treatment medication included Tylenol 1000 mg 3 times a day, as advised by doctor.
Mild symptoms all including low grade fever, aches, chills, headache, n/v. All initial symptoms relieved by analgesic.  Then 12/04/09 midnight, fever 104, severe headache, rapid breathing, rapid heart rate.  Took three hours after analgesic to fully recover. Woke next day feeling fine.
This spontaneous report as received from a nurse practitioner refers to "1 or two" patient of unknown age and gender who in September or October 2014, was vaccinated with improperly stored ZOSTAVAX (dose, route and lot number not provided). No symptoms reported. Additional information has been requested.
Report rash of left forearm and bicep day 6 post vaccination. Treatment: OTC Benadryl cream. Outcome: Complete resolution of rash by day 2. Did not interfere with ADLs.
Chills, bad body aches, very bad headache, dyspnea, tachycardia,  fatigue,  nausea
Received vaccine 6/16/09, each day following the site of injection became increasingly redder, more painful and swollen.  By 6/19/09, began itching, was the size of a softball,warm to touch, and was a hard bump, by the evening of 6/19/09 began itching.  Treatment as advised by my physician: benadryl prn, ice, if worsens go to urgent care center (as it's the weekend).
Lightheaded and Dizziness approximately 1 hour post vaccine.  Was seen in ED triage and was given meclizine 25mg oral x 1 for allergic reaction
Fever of 101.9, itchy red rash, sweated, nausea and vomiting at the night of vaccination. Patient came in today Wednesday, August 16 to inform me about the reactions. She said she had been taking BENADRYL (one capsule every 6-8 hours) but it did not seem to help with the rash. I advised her to take TYLENOL for her low grade fever and change antihistamine chemical to either ALLEGRA or ZYRTEC to see. If not improved, see a doctor. Patient agreed and left.
Per provider and Medical Assistant, the event happened after shots were given (3shots) roughly 10-15 seconds after last shot given. Patient started with her eyes rolling back and convulsing moving legs and arms in all directions. The Medical Assistant held her head and arms so that the patient would not hurt herself. The patients mother was holding her hands. Seconds after the patient regained consciousness the patient began crying as she did not know what happened . The Medical Assistant had the patient sit on the exam table and tilt the back of exam chair so that the patient can regain color because patient was very pale. Shortly after patient regained color the provider examined the patient and was cleared for discharged.
Extreme pain at injection site for 2 days Fever the next day Headache the next day Sore throat that night/into next day Muscle pain Severe fatigue ? had to call out of work the next day
Local reaction by pt report with swelling, erythema and overall feeling of low grade fever. Resolved mostly by four days.
Complete loss of mobility in left arm, severe migraine, loss of balance, dizziness, rapid heartbeat.
inflammation and swelling on injection site; Initial information received on 05-Jun-2019 regarding an unsolicited valid non-serious case received from a other healthcare professional via phone.  This case is linked to cases 2019SA157349, 2019SA157348, 2019SA157350 and 2019SA157349 (same reporter).  This case involves adult patient of unknown demographics who experienced inflammation and swelling on injection site, while received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.   On 10-Apr-2019, the patient received a first dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot number: C5602AA and expiration date: 19-Mar-2021) via intramuscular route in the left deltoid.  On an unknown date, the patient developed a non-serious inflammation and swelling on injection site (vaccination site inflammation) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  No Lab data was reported.  Final diagnosis was inflammation and swelling on injection site.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown for inflammation and swelling on injection site.  Documents held by the sender: none.
On 02/14/2023, I noticed I had bloating and pain on my left side of my abdomen. About 2 or 3 days it was not going away so I went to the urgent care, and they sent me to emergency room to make sure I did not need surgery. On 02/16/2023, they did a CAT scan exam, there was a micro abrasion in the intestine.  They admitted me to the hospital from 02/16/2023 to 02/18/2023 and I was put on an IV and was given antibiotics. Then I was determined that I had diverticulitis. The treatment was to continue the antibiotic in a pill form, and I was put on a low fiber diet at first. Within a week or two, I had to go on a high fiber diet.
Localized reaction to Left arm including redness and swelling. Now with distinct vesicles at site.
2 days after vaccine 5/4, Patient has 2+ pitting edema to left foot and lower leg and 1+ pitting edema to rt foot. There  is no pain noted to the foot or calf, no redness or increased warmth. Pedal pulses not palpable due to the swelling. (Patient doesn't have hx of lower extremity edema) 3rd day after vaccine, 5/5 Nurse reports the Patient 's left leg from the foot to the knee has 3 + edema and a positive homan's sign.  Ultra sound ordered to rule out DVT. findings negative for DVT.  Muscle spasm left calf on 5/10.  Muscle cramp and lower extremity edema resolved by 5/11/22.